Envoy Medical (COCHW) Gross Margin (2022 - 2026)

Envoy Medical has disclosed Gross Margin across 5 years of filings, most recently posting 702.56% for Q1 2026.

• Gross Margin for Q1 2026 came in at 702.56%, down 31126.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 544.87% (down 34157.0% YoY), and the FY2025 annual result was 406.22%, down 17645.0% from the prior year.
• Gross Margin came in at 702.56% for Q1 2026 at Envoy Medical, down from 642.67% in the prior quarter.
• In the past five years, Gross Margin ranged from a high of 1228.57% in Q4 2024 to a low of 2590.0% in Q4 2022.
• The 5-year median for Gross Margin is 398.75% (2023), against an average of 450.82%.
• Across the five-year window, Gross Margin surged 215000 bps in 2023 and sank 187124 bps in 2025, its largest moves.
• Envoy Medical's Gross Margin stood at 2590.0% in 2022, then soared by 83 bps to 440.0% in 2023, then soared by 379 bps to 1228.57% in 2024, then tumbled by 152 bps to 642.67% in 2025, then slipped by 9 bps to 702.56% in 2026.
• The last three Gross Margin figures came in at 702.56% (Q1 2026), 642.67% (Q4 2025), and 864.29% (Q3 2025), per Business Quant data.